Founded in 2015 in California, NeuroVasc Technologies brings over 100 years of combined expertise in neurovascular device design and development. NeuroVasc is focused on developing a portfolio of novel catheter-based technologies to facilitate broad treatment options for patients suffering stroke and other neurological conditions. Through Integrity, Collaboration, Passion, and continued Innovation, we are committed to Delivering Excellence as a dynamic creator of neurovascular devices.


Q3, 2015
  • NeuroVasc Founded
Q3, 2017
  • CE Mark Versi System
  • Japan First in Human study enrollment
Q1, 2019
  • CE mark eNVi-SR
  • Wego Group Strategic Partnership
Q4, 2019
  • Japan PI Study first enrollment
  • Irvine Facility Qualification
Q2, 2020
  • eNVoke Catheters CE Mark
Q3, 2020
  • Japan PI Study last enrollment
Q1, 2021
  • eNVac Aspiration Catheter CE Mark
Q3, 2021
  • China eNVi™-SR Randomized Controlled Trial first enrollment
Q4, 2021
  • Expansion to Worldwide Commercial Activities
Q2, 2022
  • US IDE (ENVI RCT) first enrollment (planned)
accomplishments-img-1 accomplishments-img-2
quote marks

“NeuroVasc is an innovative medical device company with employees who are passionate and committed to provide better tools to physicians and help save and improve the quality of patient’s lives. Their ingenuity and dedication are what make NeuroVasc a different kind of company.”

Jianlu Ma, CEO